BILIARY ATRESIA
Clinical trials for BILIARY ATRESIA explained in plain language.
Never miss a new study
Get alerted when new BILIARY ATRESIA trials appear
Sign up with your email to follow new studies for BILIARY ATRESIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug may help kids with rare liver disease avoid transplant
Disease control ENROLLING_BY_INVITATIONThis study tests a drug called odevixibat in 180 children with biliary atresia, a rare liver disease. The goal is to see if the drug helps children stay alive without needing a liver transplant over the long term. Children who completed a previous study can join this open-label e…
Matched conditions: BILIARY ATRESIA
Phase: PHASE3 • Sponsor: Albireo, an Ipsen Company • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
A drop of blood could spot a deadly liver disease in newborns
Diagnosis TerminatedThis trial is testing whether a dry blood spot test—using a tiny sample from a newborn's heel—can screen for biliary atresia, a serious liver condition that blocks bile flow. The test measures certain biomarkers (direct bilirubin, γ-GT, and MMP-7) that may be elevated in affected…
Matched conditions: BILIARY ATRESIA
Phase: NA • Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Diagnosis
Last updated Aug 02, 2026 00:00 UTC